Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Oxygen | HCID 977 | — |
| Reactant | Methyl Acetate | HCID 6584 | — |
| Reactant | HCID 22597936 | HCID 22597936 | — |
| Reactant | Potassium tert-butoxide | HCID 23665647 | — |
| Solvent | Acetic Acid | HCID 176 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | tert-Butanol | HCID 6386 | — |
| Product | HCID 22597961 | HCID 22597961 | 88.5% |
Reaction Steps
100 cm3 of tert-butanol are added to 5.55 g of (3RS,4RS)-4-[3-(3-chloro-6-methoxyquinolin-4-yl)propyl]-1-(tert-butyloxycarbonyl)piperidine-3-carboxylic acid in 450 cm3 of dimethyl sulfoxide, and the reaction mixture is then saturated with oxygen for 30 minutes. A solution of 3.36 g of potassium tert-butoxide in 40 cm3 of tert-butanol is then added over 40 minutes. The mixture is allowed to stir for 2 hours while maintaining the oxygen flow rate, and then the medium is cooled to around 0° C. in order to add 1.8 cm3 of acetic acid in 30 cm3 of distilled water. 1000 cm3 of distilled water and 1000 cm3 of methyl acetate are then poured onto the reaction medium. The organic phase is then washed with 8 times 250 cm3 of distilled water then with 2 times 100 cm3 of sodium chloride. The pooled aqueous phases are re-extracted with 500 cm3 of ethyl acetate. The two organic phases are pooled and then dried over magnesium sulfate for 1 hour. Filtration is carried out through a sintered glass funnel, followed by concentration under reduced pressure (2 kPa; 45° C.). The residue is taken up in 250 cm3 of methyl acetate and 100 cm3 of distilled water. The organic phase is washed with 3 times 50 cm3 of distilled water and then with 50 cm3 of a saturated aqueous sodium chloride solution. Drying is carried out over magnesium sulfate for 1 hour, filtration is carried out through a sintered glass funnel, and then evaporation is carried out under reduced pressure (2 kPa; 45° C.). 5.08 g of (3RS,4RS)-4-[3-(R,S)-hydroxy-3-(3-chloro-6-methoxyquinolin-4-yl)propyl]-1-(tert-butyloxy-carbonyl)piperidine-3-carboxylic acid are obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06841562B2 |
|---|
| Source dataset | uspto-grants-2005_01 |
|---|
| ORD ID | ord-a27d035b0c124c66a63138d167b6a58d |
|---|
| Source note | uspto-grants-2005_01 |
|---|